Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.77%
SPX
+0.83%
IXIC
+0.98%
FTSE
+0.24%
N225
+1.03%
AXJO
+0.51%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks

IONS has been in the news 643% more than usual

Sep 02, 2025, 6:32 PM
4.49%
What does IONS do
Ionis Pharmaceuticals, headquartered in Carlsbad, California, develops drugs using antisense technology and has five marketed medicines, including SPINRAZA and QALSODY, with a pipeline focused on neurology and cardiology. The company employs 927 people and has nine medicines in Phase III development.
IONS has been in the news recently: Ionis Pharmaceuticals, Inc. announced topline results from its Phase 3 CORE and CORE2 studies of olezarsen, a treatment for severe hypertriglyceridemia. Meanwhile, U.S. stock markets experienced a decline on the same day, with notable movements in other companies unrelated to Ionis.
📡️ Health Care
In The News

More Signals

Feature in Progress
This section is under development. Check back soon for updates!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.